SCOPE International

What SCOPE International does

SCOPE International AG is an independent, full-service Contract Research Organization (CRO) headquartered in Mannheim, Germany, providing clinical development and consulting services to pharmaceutical companies across all clinical phases (I–IV). Founded in 2000, the company operates 11 offices across Europe with a global partner network spanning 30 countries, and has conducted over 300 clinical studies caring for more than 88,000 patients. SCOPE delivers services across eight core solution areas: Clinical Operations, Medical Writing, Clinical Data Management, Biostatistics & SAS Programming, Safety Management, Quality Management, Regulatory Affairs, and Strategic Development, with therapeutic specialization in pain, women's health, respiratory, neurology & neuropsychiatry, infectious diseases, and Advanced Therapy Medicinal Products (ATMP).

The company's technical foundation is a proprietary in-house technology platform encompassing CTMS, eTMF, EDC/ePRO/RTMS, Automated Safety Reporting, eConsent, Medical Coding, and a Safety Database, supplemented by an AI module positioned for clinical operations automation. The platform is described as custom-built for seamless integrations and rapid development of client-specific solutions. SCOPE positions itself competitively against large CROs by emphasizing flexibility, dedicated project leadership, and service quality over billable-hour tracking, and adheres to FDA, EMA, and GCP compliance standards.

SCOPE generates revenue through professional services contracts with pharmaceutical clients on a quote-based, tailored engagement model. Go-to-market is direct enterprise sales with consultative relationship-building rather than transactional billing. The company is privately held with no disclosed parent company, venture capital, or private equity ownership, and has been self-sustaining through service revenue since founding. No financial figures, funding events, or M&A activity are publicly disclosed.

Name

SCOPE International

Legal name

SCOPE International AG

Website

https://scope-international.online

Company type

Private

Founded year

2000

Operating status

Operating

Headcount range

101–250 employees

Short description

SCOPE International AG is an independent, full-service Contract Research Organization headquartered in Mannheim, Germany, providing clinical development and consulting services to pharmaceutical companies across all phases (I-IV) from 11 European offices.

Ownership category

akta.pro rank

Product category

Contract Research Organization (CRO) / Clinical Research Services

NAICS

Scientific Research and Development Services (5417), All Other Professional, Scientific, and Technical Services (541990)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

Keywords

• Clinical research services
• Contract research organization
• Clinical trial management
• Pharmaceutical drug development
• Biostatistics and pharmacovigilance

Headquarters

HQ city

Mannheim

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Clinical Development Services: Full-service CRO providing comprehensive clinical development and consulting services including Clinical Operations, Medical Writing, Clinical Data Management, Biostatistics & SAS Programming, Safety Management, Quality Management, Regulatory Affairs, and Strategic Development. Revenue is generated through service contracts with pharmaceutical companies across all clinical phases (I-IV).

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

SCOPE International is an independent, full-service Contract Research Organization (CRO) providing clinical development and consulting services to pharmaceutical companies. Its offerings cover Clinical Operations, Medical Writing, Clinical Data Management, Biostatistics & SAS Programming, Safety Management, Quality Management, Regulatory Affairs, and Strategic Development, supported by a proprietary in-house technology platform (CTMS, eTMF, EDC/ePRO/RTMS, Automated Safety Reporting, eConsent, Medical Coding, Safety Database, and AI capabilities) used to streamline clinical research across all trial phases (I–IV).

Product overview

SCOPE International is an independent, full-service Contract Research Organization (CRO) offering a comprehensive portfolio of clinical development services organized around two main pillars: expert consulting services and proprietary technology platforms. The service offerings include Clinical Operations, Medical Writing, Clinical Data Management, Biostatistics & SAS Programming, Safety Management, Quality Management, Regulatory Affairs, and Strategic Development. These services are supported by a suite of proprietary technology platforms including AI (Artificial Intelligence), CTMS, eTMF, EDC/ePRO/RTMS, Automated Safety Reporting, Customized Solutions, eConsent, Medical Coding, and Safety Database. The technology stack represents SCOPE's own built platform designed to streamline clinical research processes, with flexible approach enabling seamless integrations and rapid development of new features as needed. The company operates with 11 offices across Europe and has conducted over 300 studies in 30 countries since 2000.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Operations Comprehensive clinical trial management services covering site selection, monitoring, and project coordination across all study phases (I–IV) for pharmaceutical clients.
• Medical Writing Professional medical and clinical documentation services including protocol development, clinical study reports, and regulatory submission writing for pharmaceutical sponsors.
• Clinical Data Management End-to-end data management solutions including database design, data entry, validation, and discrepancy management for clinical trials.
• Biostatistics & SAS Programming Statistical analysis and SAS programming services for clinical data, including study design, statistical analysis plans, and regulatory submission support.
• Safety Management Pharmacovigilance and safety monitoring services including adverse event reporting, signal detection, and regulatory safety submissions.
• Quality Management Quality assurance and control services ensuring compliance with FDA, EMA, and GCP standards throughout clinical development.
• Regulatory Affairs Strategic regulatory consulting and submission services for drug development programs across global markets.
• Strategic Development Strategic consulting services for clinical development planning, program optimization, and market access strategies for pharmaceutical sponsors.

Quantifiable outcome

• Over 300 studies conducted in 30 countries
• +3 more outcomes

Named customers3 records

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Scale indicators6 records

Recent moves4 records

Expansion highlights4 records

Direct peers

• ICON plc: Large global full-service CRO offering clinical operations, biostatistics, data management, regulatory, and pharmacovigilance across all phases — directly overlapping SCOPE's service portfolio at greater scale and broader geographic reach.
• PSI CRO: Privately-held, European-headquartered full-service CRO operating across all clinical phases. Highly comparable in size, geographic base, independent ownership structure, and full-service clinical offerings.
• Parexel International: Global full-service CRO with overlapping clinical operations, biostatistics, regulatory affairs, and pharmacovigilance capabilities. Competes for the same enterprise pharma RFPs as SCOPE, with deeper resources and broader geographic coverage.
• Syneos Health: Full-service biopharmaceutical solutions organization combining CRO services with commercial capabilities. Competes head-to-head with SCOPE in clinical development services for pharma and biotech sponsors across all phases.
• Worldwide Clinical Trials: Mid-size, privately-held full-service CRO with comparable therapeutic depth (oncology, neuroscience, rare diseases) and a similar model of serving mid-size pharma sponsors with full-service capabilities. Direct head-to-head competitor for SCOPE's target customer profile.
• Medpace: Mid-size, publicly-traded full-service CRO with a similar model of therapeutic specialization (oncology, CNS, metabolic), proprietary technology stack, and a focus on full-service clinical development for mid-size pharma and biotech. The closest publicly traded analog in positioning and scale philosophy.

Emerging players

• Clinipace Worldwide: Mid-size, privately-held full-service CRO with comparable therapeutic-area focus and technology-forward approach. Comparable in scale and positioning as an alternative to mega-CROs for mid-size pharma and biotech sponsors.
• Ergomed: Smaller full-service CRO with specialty expertise in oncology, rare disease, and pharmacovigilance. Comparable in therapeutic focus and mid-tier positioning, though smaller in scale and recently consolidated under private equity ownership.

Broad incumbents

• IQVIA: Largest global CRO and life sciences services firm, offering clinical development alongside RWD, technology, and consulting. A broad incumbent competitor that dominates enterprise pharma RFPs against which SCOPE positions itself as an independent alternative.
• Labcorp Drug Development (formerly Covance): Large CRO bundled with central laboratory services, offering end-to-end clinical development including bioanalytical and diagnostics. Competes with SCOPE on enterprise full-service contracts, particularly where laboratory integration matters.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/scope-international-ag

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SCOPE International